Condition
Lymphatic Abnormalities
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05731141Recruiting
A Prospective Natural History Study of Lymphatic Anomalies
NCT07131293Recruiting
European Registry Study on Lymphatic Interventions
NCT06892964Not ApplicableRecruiting
Institution of an Italian Registry and Biobank for Biological Sample Collection
NCT05934578Not ApplicableCompleted
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
NCT04394507Completed
Lymphatic Function in Patients With a Fontan Circulation From Brazil
NCT03379805UnknownPrimary
Lymphatic Function in Patients With a Fontan-Kreutzer Circulation
Showing all 6 trials